Analyst Price Targets — SNDL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 28, 2026 6:22 pm | — | Industrial Alliance Securities | $3.50 | $1.22 | TheFly | SNDL price target lowered to $3.50 from $5 at Alliance Global |
| July 17, 2024 11:42 am | Yewon Kang | Canaccord Genuity | $3.25 | $2.19 | TheFly | SNDL assumed with a Speculative Buy at Canaccord |
| November 28, 2022 2:08 pm | — | Cantor Fitzgerald | $3.60 | $2.52 | Benzinga | Cantor Fitzgerald Maintains Neutral on SNDL, Raises Price Target to $3.6 |
| May 22, 2022 4:28 pm | Tamy Chen | BMO Capital | $5.00 | $4.16 | Pulse 2.0 | Sundial Growers (SNDL) Stock: $0.50 Price Target And Market Perform Rating |
| May 3, 2022 7:21 am | — | BMO Capital | $7.00 | $4.91 | Benzinga | BMO Capital Upgrades Sundial Growers to Market Perform, Raises Price Target to $0.7 |
Latest News for SNDL
EDMONTON, Alberta, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) today announced the successful completion of a European Union Good Manufacturing Practice ("EU-GMP") audit at its Atholville, New Brunswick cultivation facility. The successful audit reinforces SNDL's ability to participate in regulated international medical cannabis markets and reflects the Company's…
Earlier this week, SNDL Inc. SNDL reported dismal second-quarter 2026 results, with earnings and sales missing consensus estimates.
SNDL reported weaker Q2-2026 financial performance earlier this week with lower revenue YoY and a net loss. SNDL completed the restructuring of its US Skymint assets and is well-positioned to enter US THC markets upon rescheduling. The cannabis sector remains weak due to uncertainty; the DEA hearing to reschedule cannabis has no updates.
SNDL Inc. (SNDL) Q2 2026 Earnings Call Transcript
SNDL NASDAQ: SNDL reported lower second-quarter revenue and gross profit as demand weakness across liquor and cannabis markets, cannabis-production ramp-up costs and promotional activity weighed on results. The company said it continued to generate positive operating cash flow and improved free cash flow year over year, while accelerating share repurchases and advancing a restructuring involving U.S. cannabis…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for SNDL.
Senate Trading
No Senate trades found for SNDL.
U.S. House Trading
No House trades found for SNDL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.